Works matching IS 0741238X AND DT 2023 AND VI 40 AND IP 9
Results: 35
Neuroendocrine Component in Extrahepatic Cholangiocarcinoma is Associated with Better Survival: Data from the SEER Study.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 4032, doi. 10.1007/s12325-023-02597-9
- By:
- Publication type:
- Article
Letter to the Editor Regarding "Cost-Effectiveness of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single Agent Pembrolizumab for High-Risk Early-Stage Triple Negative Breast Cancer in the United States".
- Published in:
- 2023
- By:
- Publication type:
- Letter
Correction to: Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Desmoid Tumors: A Comprehensive Review.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 3697, doi. 10.1007/s12325-023-02592-0
- By:
- Publication type:
- Article
Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 4074, doi. 10.1007/s12325-023-02589-9
- By:
- Publication type:
- Article
Study on the Relationship Between Differentially Expressed Proteins in Breast Cancer and Lymph Node Metastasis.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 4004, doi. 10.1007/s12325-023-02588-w
- By:
- Publication type:
- Article
Narrative Review of Topiramate: Clinical Uses and Pharmacological Considerations.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 3626, doi. 10.1007/s12325-023-02586-y
- By:
- Publication type:
- Article
Assessing the Effects of Changing Patterns of Inhaled Corticosteroid Dosing and Adherence with Fluticasone Furoate and Budesonide on Asthma Management.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 4042, doi. 10.1007/s12325-023-02585-z
- By:
- Publication type:
- Article
Characterizing Opioid Use Disorder Encounters in the Midwest Region, USA.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 4093, doi. 10.1007/s12325-023-02584-0
- By:
- Publication type:
- Article
Dose Nomogram of Individualization of the Initial Follicle-Stimulating Hormone Dosage for Patients with Polycystic Ovary Syndrome Undergoing IVF/ICSI with the GnRH-Ant Protocol: A Retrospective Cohort Study.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 3971, doi. 10.1007/s12325-023-02582-2
- By:
- Publication type:
- Article
Application of Autologous Hair Transplantation Technique in Children with Cicatricial Alopecia.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 4024, doi. 10.1007/s12325-023-02581-3
- By:
- Publication type:
- Article
Factors That Predict a Sustained Humoral Response to COVID-19 Vaccines in Kidney Transplant Recipients.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 3956, doi. 10.1007/s12325-023-02580-4
- By:
- Publication type:
- Article
Real-World Evaluation of the Management, Treatment Pathways and Outcome of Melanoma Patients with Target Therapies in Italy.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 3875, doi. 10.1007/s12325-023-02578-y
- By:
- Publication type:
- Article
Large-Scale, Multicenter, Prospective Registry Study of Ripretinib in Advanced GIST: A Real-World Study from China.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 3817, doi. 10.1007/s12325-023-02576-0
- By:
- Publication type:
- Article
Pharmacokinetics, Safety, and Efficacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Plaque Psoriasis: A Phase 1, Single- and Multiple-Dose Study.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 3804, doi. 10.1007/s12325-023-02575-1
- By:
- Publication type:
- Article
Budget Impact Analysis of Expanding Gliflozin Coverage in the CKD Population: A French Perspective.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 3751, doi. 10.1007/s12325-023-02574-2
- By:
- Publication type:
- Article
Analyses of Dupilumab-Related Ocular Adverse Drug Reactions Using the WHO's VigiBase.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 3830, doi. 10.1007/s12325-023-02573-3
- By:
- Publication type:
- Article
First Line Medical Treatment of Metastatic Renal Cell Carcinoma: A Podcast on Choosing Wisely and Managing Safely.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 3620, doi. 10.1007/s12325-023-02571-5
- By:
- Publication type:
- Article
Model-Informed Support of Dose Selection for Prophylactic Treatment with Dalcinonacog Alfa in Adult and Paediatric Hemophilia B Patients.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 3739, doi. 10.1007/s12325-023-02570-6
- By:
- Publication type:
- Article
A Podcast Discussion on the Current Treatment Landscape for Renal Cell Carcinoma.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 3610, doi. 10.1007/s12325-023-02569-z
- By:
- Publication type:
- Article
The Added Prognostic Value of Oncotype Recurrence Score to AJCC Prognostic Staging System in Stage III ER+/HER2− Breast Cancer.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 3912, doi. 10.1007/s12325-023-02566-2
- By:
- Publication type:
- Article
Efficacy and Safety of Pirfenidone in Advanced Versus Non-Advanced Idiopathic Pulmonary Fibrosis: Post-Hoc Analysis of Six Clinical Studies.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 3937, doi. 10.1007/s12325-023-02565-3
- By:
- Publication type:
- Article
Botulinum Toxin Utilization, Treatment Patterns, and Healthcare Costs Among Patients with Spasticity or Cervical Dystonia in the US.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 3986, doi. 10.1007/s12325-023-02563-5
- By:
- Publication type:
- Article
Pharyngeal Reconstruction Methods to Reduce the Risk of Pharyngocutaneous Fistula After Primary Total Laryngectomy: A Scoping Review.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 3681, doi. 10.1007/s12325-023-02561-7
- By:
- Publication type:
- Article
Real-World Effectiveness of rFIXFc Prophylaxis in Patients with Haemophilia B Switched from Standard Half-Life Therapy in Three European Countries.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 3770, doi. 10.1007/s12325-023-02559-1
- By:
- Publication type:
- Article
The Relationship Between Signature Time and Functional Health Literacy: Results from a Prospective Study of an Urban Low-Income Population Receiving Long-Term Anticoagulation.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 3926, doi. 10.1007/s12325-023-02556-4
- By:
- Publication type:
- Article
Impact of Pertuzumab and Ado-Trastuzumab Emtansine on Cumulative Avoidance of Recurrence Among Women Treated for Locally Advanced, Inflammatory, or Early-Stage Nonmetastatic HER2-Positive Breast Cancer in the United States.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 3857, doi. 10.1007/s12325-023-02554-6
- By:
- Publication type:
- Article
Societal Utilities for Cognitive Impairment in Schizophrenia: Developing a Preference-Based Scoring Algorithm Based on the Schizophrenia Cognition Rating Scale.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 4060, doi. 10.1007/s12325-023-02553-7
- By:
- Publication type:
- Article
Burden and Treatment of Achondroplasia: A Systematic Literature Review.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 3639, doi. 10.1007/s12325-023-02549-3
- By:
- Publication type:
- Article
Matching-Adjusted Indirect Comparison Between Risankizumab and Ustekinumab for Induction and Maintenance Treatment of Moderately to Severely Active Crohn's Disease.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 3896, doi. 10.1007/s12325-023-02546-6
- By:
- Publication type:
- Article
Sugammadex Reduced the Incidence of Postoperative Pulmonary Complications in Susceptible Patients Identified by ARISCAT Risk Index: Systematic Review and Meta-analysis.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 3784, doi. 10.1007/s12325-023-02535-9
- By:
- Publication type:
- Article
Factors Associated with Severe COVID-19 Among Patients with Rheumatoid Arthritis: A Large, Nationwide Electronic Health Record Cohort Study in the United States.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 3723, doi. 10.1007/s12325-023-02533-x
- By:
- Publication type:
- Article
B-Clear Phase 2b Study Design: Establishing the Efficacy and Safety of Bepirovirsen in Patients with Chronic Hepatitis B Virus Infection.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 4101, doi. 10.1007/s12325-023-02531-z
- By:
- Publication type:
- Article
Correction to: A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 9, p. 3599, doi. 10.1007/s12325-023-02513-1
- By:
- Publication type:
- Article